160 related articles for article (PubMed ID: 16526315)
21. Endothelial nitric oxide synthase affects the progression of autosomal dominant polycystic kidney disease.
Reiterová J; Merta M; Tesar V; Stekrová J
Kidney Blood Press Res; 2002; 25(2):87-90. PubMed ID: 12077489
[TBL] [Abstract][Full Text] [Related]
22. Genetic variability of endothelin-1 system in gestational hypertension and preeclampsia.
Seremak-Mrozikiewicz A; Barlik M; Perlik M; Kurzawińska G; Drews K
Ginekol Pol; 2011 May; 82(5):363-70. PubMed ID: 21851036
[TBL] [Abstract][Full Text] [Related]
23. Risk of coronary artery disease as influenced by variants of the human endothelin and endothelin-converting enzyme genes.
Bühler K; Ufer M; Müller-Marbach A; Brinkmann U; Laule M; Stangl V; Roots I; Stangl K; Cascorbi I
Pharmacogenet Genomics; 2007 Jan; 17(1):77-83. PubMed ID: 17264805
[TBL] [Abstract][Full Text] [Related]
24. The ACE insertion/deletion polymorphism has no influence on progression of renal function loss in autosomal dominant polycystic kidney disease.
van Dijk MA; Breuning MH; Peters DJ; Chang PC
Nephrol Dial Transplant; 2000 Jun; 15(6):836-9. PubMed ID: 10831637
[TBL] [Abstract][Full Text] [Related]
25. Polymorphism in endothelin-related genes limits exercise-induced decreases in arterial stiffness in older subjects.
Iemitsu M; Maeda S; Otsuki T; Sugawara J; Tanabe T; Jesmin S; Kuno S; Ajisaka R; Miyauchi T; Matsuda M
Hypertension; 2006 May; 47(5):928-36. PubMed ID: 16567585
[TBL] [Abstract][Full Text] [Related]
26. Effects of endothelial nitric oxide synthase gene on end stage renal disease progression in autosomal dominant polycystic kidney disease.
Xue C; Zhou CC; Sun LJ; He LL; Xu CG; Dai B; Mei CL
Nephrology (Carlton); 2014 Oct; 19(10):630-7. PubMed ID: 24995932
[TBL] [Abstract][Full Text] [Related]
27. No association of the TGF-beta1 gene polymorphisms with the renal progression in autosomal dominant polycystic kidney disease (ADPKD) patients.
Lee JG; Ahn C; Yoon SC; Park JH; Eo HS; No JJ; Kim KH; Lee EJ; Hwang YH; Hwang DY; Kim YS; Han JS; Kim S; Lee JS; Kim SH
Clin Nephrol; 2003 Jan; 59(1):10-6. PubMed ID: 12572925
[TBL] [Abstract][Full Text] [Related]
28. Influence of ACE I/D gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease: a meta-analysis.
Pereira TV; Nunes AC; Rudnicki M; Magistroni R; Albertazzi A; Pereira AC; Krieger JE
Nephrol Dial Transplant; 2006 Nov; 21(11):3155-63. PubMed ID: 16935894
[TBL] [Abstract][Full Text] [Related]
29. Influence of ACE (I/D) and G460W polymorphism of alpha-adducin in autosomal dominant polycystic kidney disease.
Persu A; El-Khattabi O; Messiaen T; Pirson Y; Chauveau D; Devuyst O
Nephrol Dial Transplant; 2003 Oct; 18(10):2032-8. PubMed ID: 13679477
[TBL] [Abstract][Full Text] [Related]
30. Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease.
Choukroun G; Itakura Y; Albouze G; Christophe JL; Man NK; Grünfeld JP; Jungers P
J Am Soc Nephrol; 1995 Dec; 6(6):1634-42. PubMed ID: 8749691
[TBL] [Abstract][Full Text] [Related]
31. Epidermal growth factor receptor polymorphism and autosomal dominant polycystic kidney disease.
Magistroni R; Manfredini P; Furci L; Ligabue G; Martino C; Leonelli M; Scapoli C; Albertazzi A
J Nephrol; 2003; 16(1):110-5. PubMed ID: 12653106
[TBL] [Abstract][Full Text] [Related]
32. Evidence for association of endothelial cell nitric oxide synthase gene polymorphism with earlier progression to end-stage renal disease in a cohort of Hellens from Greece and Cyprus.
Lamnissou K; Zirogiannis P; Trygonis S; Demetriou K; Pierides A; Koptides M; Deltas CC
Genet Test; 2004; 8(3):319-24. PubMed ID: 15727257
[TBL] [Abstract][Full Text] [Related]
33. Incident renal events and risk factors in autosomal dominant polycystic kidney disease: a population and family-based cohort followed for 22 years.
Dicks E; Ravani P; Langman D; Davidson WS; Pei Y; Parfrey PS
Clin J Am Soc Nephrol; 2006 Jul; 1(4):710-7. PubMed ID: 17699277
[TBL] [Abstract][Full Text] [Related]
34. Influence of angiotensin converting enzyme (
Ramanathan G; Ghosh S; Elumalai R; Periyasamy S; Lakkakula BV
Indian J Med Res; 2016 Jun; 143(6):748-755. PubMed ID: 27748299
[TBL] [Abstract][Full Text] [Related]
35. A promoter polymorphism of the alpha 8 integrin gene and the progression of autosomal-dominant polycystic kidney disease.
Zeltner R; Hilgers KF; Schmieder RE; Porst M; Schulze BD; Hartner A
Nephron Clin Pract; 2008; 108(3):c169-75. PubMed ID: 18277079
[TBL] [Abstract][Full Text] [Related]
36. Endothelin-converting enzyme-1 promoter polymorphisms and susceptibility to sporadic late-onset Alzheimer's disease in a Chinese population.
Jin Z; Luxiang C; Huadong Z; Yanjiang W; Zhiqiang X; Hongyuan C; Lihua H; Xu Y
Dis Markers; 2009; 27(5):211-5. PubMed ID: 20037208
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin-converting enzyme activity and the ACE Alu polymorphism in autosomal dominant polycystic kidney disease.
Schiavello T; Burke V; Bogdanova N; Jasik P; Melsom S; Boudville N; Robertson K; Angelicheva D; Dworniczak B; Lemmens M; Horst J; Todorov V; Dimitrakov D; Sulowicz W; Krasniak A; Stompor T; Beilin L; Hallmayer J; Kalaydjieva L; Thomas M
Nephrol Dial Transplant; 2001 Dec; 16(12):2323-7. PubMed ID: 11733623
[TBL] [Abstract][Full Text] [Related]
38. [AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: HOW AND WHY SHOULD WE IDENTIFY THE PATIENTS "RAPIDLY PROGRESSING" TO END-STAGE RENAL DISEASE?].
Bodson A; Meunier P; Krzesinski JM; Jouret F
Rev Med Liege; 2016 Apr; 71(4):184-92. PubMed ID: 27295898
[TBL] [Abstract][Full Text] [Related]
39. Role of renin-angiotensin-aldosterone system gene polymorphisms and hypertension-induced end-stage renal disease in autosomal dominant polycystic kidney disease.
Ramanathan G; Elumalai R; Periyasamy S; Lakkakula B
Iran J Kidney Dis; 2014 Jul; 8(4):265-77. PubMed ID: 25001132
[TBL] [Abstract][Full Text] [Related]
40. Differential binding of transcription factor E2F-2 to the endothelin-converting enzyme-1b promoter affects blood pressure regulation.
Funke-Kaiser H; Reichenberger F; Köpke K; Herrmann SM; Pfeifer J; Orzechowski HD; Zidek W; Paul M; Brand E
Hum Mol Genet; 2003 Feb; 12(4):423-33. PubMed ID: 12566389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
